Office of the Director Amended; Notice of Meeting, 18660 [2017-07939]
Download as PDF
<![CDATA[
18660
Federal Register / Vol. 82, No. 75 / Thursday, April 20, 2017 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID Clinical Trial
Implementation Cooperative Agreement
(U01).
Date: May 11, 2017.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Jay R. Radke, Ph.D., AIDS
Review Branch, Scientific Review Program,
Division of Extramural Activities, Room
#3G11B, National Institutes of Health, NIAID,
5601 Fishers Lane MSC–9823, Bethesda, MD
20892–9823, (240) 669–5046, jay.radke@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 14, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07935 Filed 4–19–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director Amended; Notice
of Meeting
Notice is hereby given of a change in
the meeting of the NIH Clinical Center
Research Hospital Board, on Friday,
April 28, 2017, 8:30 a.m. to April 28,
2017: 5:00 p.m., National Institutes of
Health, Building 31, Conference Room
6C6, Bethesda, Maryland 20892 which
was published in the Federal Register
on Thursday, April 13, 2017, 82 FR
17847.
The meeting notice is amended to
change the time of the closed session.
The closed session that was previously
announced being held from 3:20 p.m. to
5:00 p.m. to discuss the identification of
candidates for leadership roles will now
be held from 11:45 a.m. to 12:30 p.m.
Dated: April 14, 2017.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07939 Filed 4–19–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the infor
mation shall have practical utility; (b)
the accuracy of the agency’s estimate of
the burden of the proposed collection of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: State Targeted
Response to the Opioid Crisis Grant
Program Reports—NEW
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is authorized under Section
1003 of the 21st Century Cures Act, as
amended, to support a grant program,
for up to 2 years, that addresses the
supplemental activities pertaining to
opioids currently undertaken by the
state agency or territory and will
support a comprehensive response to
the opioid epidemic. The State Targeted
Response to the Opioid Crisis Grant
(Opioid STR) program addresses
Healthy People 2020, Substance Abuse
Topic Area HP 2020–SA.The primary
purpose of Opioid STR is to address the
opioid crisis by increasing access to
treatment, reducing unmet treatment
need, and reducing opioid overdose
related deaths through the provision of
prevention, treatment and recovery
activities for opioid use disorder (OUD)
(including prescription opioids as well
as illicit drugs such as heroin).
There will be up to 59 (states and
jurisdictions) award recipients in this
program. All funded states and
jurisdictions will be asked to report on
their implementation and performance
through an online data collection
system. Award recipients will report
performance on the following measures
specific to this program: Number of
people who receive OUD treatment,
number of people who receive OUD
recovery services, number of providers
implementing medication-assisted
treatment, and the number of OUD
prevention and treatment providers
trained, to include NPs, PAs, as well as
physicians, nurses, counselors, social
workers, case managers, etc.
This information will be collected at
the mid-point and conclusion of each
grant award year.
Additionally, each award recipient
will describe the purposes for which the
grant funds received were expended and
the activities under the program, and
the ultimate recipients of amounts
provided to the grantee in the grants.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
ANNUALIZED ESTIMATED BURDEN HOURS FOR THE PROGRESS REPORT
Respondent
Number of
respondents
Number of
responses
per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
State and Jurisdictions .........................................................
57
2
114
8.0
912
VerDate Sep<11>2014
17:27 Apr 19, 2017
Jkt 241001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\20APN1.SGM
20APN1
]]>Agencies
[Federal Register Volume 82, Number 75 (Thursday, April 20, 2017)]
[Notices]
[Page 18660]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07939]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director Amended; Notice of Meeting
Notice is hereby given of a change in the meeting of the NIH
Clinical Center Research Hospital Board, on Friday, April 28, 2017,
8:30 a.m. to April 28, 2017: 5:00 p.m., National Institutes of Health,
Building 31, Conference Room 6C6, Bethesda, Maryland 20892 which was
published in the Federal Register on Thursday, April 13, 2017, 82 FR
17847.
The meeting notice is amended to change the time of the closed
session. The closed session that was previously announced being held
from 3:20 p.m. to 5:00 p.m. to discuss the identification of candidates
for leadership roles will now be held from 11:45 a.m. to 12:30 p.m.
Dated: April 14, 2017.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07939 Filed 4-19-17; 8:45 am]
BILLING CODE 4140-01-P
